Glenmark Pharmaceuticals gets FDA approval for Lexiscan Injection generic
Glenmark Pharmaceuticals said that it has secured tentative approval from the US Food & Drug Administration (FDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe. The drug is the generic version of Lexiscan Injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas US. Lexiscan Injection, 0.4 mg/5 mL (0.08 mg/mL) had annual sales […]